CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −650 | $550.40 | $358K | 41,153 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $551.37 | $353K | 40,513 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 78,910 | ||
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,737 | $545.99 | $948K | 48,276 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,808 | $546.88 | $1.5M | 45,468 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,366 | $547.85 | $1.3M | 43,102 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,289 | $548.81 | $707K | 41,813 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,202 | $549.77 | $661K | 40,611 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −98 | $550.53 | $54K | 40,513 |
| 2026-06-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 88,410 | ||
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $117.76 | $1.2M | 28,876 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $539.64 | $65K | 28,756 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −480 | $541.14 | $260K | 28,276 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −440 | $542.78 | $239K | 27,836 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,086 | $544.11 | $591K | 26,750 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,545 | $544.94 | $842K | 25,205 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,129 | $545.89 | $616K | 24,076 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,033 | $547.00 | $565K | 23,043 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,749 | $548.04 | $1.5M | 20,294 |
Page 88 of 120 · 2,391 trades